News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Monday, July 24, 2017

Top Breaking News

News from Around the Web

Press Releases
Theratechnologies (TH.TO) Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection)
e-Therapeutics' New CEO Takes The Ax To Four Drug Discovery Programs
Pfizer (PFE)-Backed San Diego Biotech eFFECTOR Nabs $38.6 Million, Touting A Total Raise Of $150 Million
HemaCare (HEMA) Inks Lease for New HQ Relocation and Expansion
GlaxoSmithKline (GSK) Receives FDA Approval For A New Self-Injectable Formulation Of Benlysta (Belimumab) For Systemic Lupus Erythematosus
Shionogi Announces Positive Top-Line Results For S-033188 Phase III Study (CAPSTONE-1) In Otherwise Healthy Influenza Patients
ORYZON Genomics Presents Final Data On The Phase I Trial With ORY-2001 At The Alzheimer's Association International Conference (AAIC-2017)
Gilead (GILD) Boosted By New Late-Stage HIV Data
Merck & Co. (MRK)'s Once-Daily HIV Drug Works Just As Well As Twice-Daily Formulation
Pfizer (PFE) Announces Positive Top-Line Results From The Comparative REFLECTIONS B7391003 Study For PF-06439535, A Potential Biosimilar To Avastin 1 (Bevacizumab)
San Diego's Cytori (CYTX) Plunges Scleroderma Med Flunks Phase III Study
BioLight Life Sciences Reports Successful Results In Phase I/IIa Clinical Trial For Glaucoma Insert
Reata Pharmaceuticals, Inc.’s Bardoxolone Methyl Demonstrated Improved Kidney Function In Patients With Alport Syndrome In Ongoing Phase II Portion Of Phase II/III Cardinal Study
Genocea (GNCA) Reports Positive Top-Line 12-Month Phase IIb Data For GEN-003 In Genital Herpes
TRANSGENE (ENX:TNG) Announces Cancer Research Publication Confirming The Potential Of Its Next Generation Armed Engineered Oncolytic Virus
Janssen Sciences Ireland UC Releases: Data Published In Lancet Shows High Efficacy At 96 Weeks For First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
Napo Pharmaceuticals, Inc. Release: New Data Shows Dramatic Reduction In Chronic Diarrhea Episodes With Crofelemer (Mytesi) Treatment
Johnson & Johnson (JNJ) Announces Encouraging First-In-Human Clinical Data For Investigational HIV Preventive Vaccine
H3 Biomedicine And University of British Columbia Scientists Report Preclinical Data Describing Immune Evasion Mechanism In Muscle-Invasive Bladder Cancer
Bristol-Myers Squibb (BMY) Release: FDA Expands Approval Of Yervoy (Ipilimumab) To Include Pediatric Patients 12 Years And Older With Unresectable Or Metastatic Melanoma
Tetra Bio-Pharma (TBP) Accelerates Growth Strategy With Appointment Of Bernard Fortier As CEO
Jeff Boutelle Appointed Chief Executive Officer Of Pharmavite
Xbrane Biopharma: Spherotide Granted Market Authorization In Iran
Biohaven (BHVN) Enrolls First Patient In Pivotal Phase III Clinical Trial Of Oral Rimegepant For The Acute Treatment Of Migraine
Eiger Biopharma Completes Enrollment In Phase II LIMT HDV Study Of Pegylated Interferon Lambda In Hepatitis Delta Virus Infection
DelMar Pharma Receives Approval From China's Human Genetic Resources Administration To Initiate Phase II Clinical Trial In Newly Diagnosed GBM
Stealth Biotherapeutics Initiates Phase II/III Study of Elamipretide In Patients With Barth Syndrome
Tocagen Receives EMA Priority Medicines (PRIME) Designation For Toca 511 In High Grade Glioma
BlackThorn Therapeutics Enrolls First Patient In Phase IIa Study Of Lead Compound, BTRX-246040, In Major Depressive Disorder
NovoCure Announces A Phase Ib Clinical Trial To Evaluate The Safety Of Marizomib And Temozolomide In Combination With Optune® As Adjuvant Therapy In Patients With Glioblastoma
Valneva Receives FDA Fast Track Designation For Its Lyme Disease Vaccine Candidate VLA15
CDC Release: Country With World's Highest HIV Prevalence Is Now Controlling Its HIV Epidemic
Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation
Repositive Release: New Research Shows How Repositive Platform Can Be Used To Leverage Direct To Consumer Genomic Data For Research
Breakthrough In Advanced Kidney Disease By Stem Cell Genetic Med
Boehringer Ingelheim Release: People With Idiopathic Pulmonary Fibrosis (IPF) Reveal High Burden Of Disease In New Survey
The Alliance for Regenerative Medicine (ARM) Announces Second Reimbursement And Market Access-Focused White Paper In Three-Part Series Published In In Vivo
BriaCell Expands Targeted Pipeline Via Acquisition Of Sapientia Pharmaceuticals
Concert Pharma (CNCE) Announces Termination Of The HSR Act Waiting Period For CTP-656 Asset Purchase Agreement With Vertex (VRTX)
Seattle Genetics (SGEN) Announces Clinical Collaboration To Expand The Therapeutic Evaluation Of SGN-LIV1A In Triple Negative Breast Cancer
STA Pharmaceutical Signs Supply Agreement With Tesaro (TSRO)
Evotec AG (EVTG.F) And Bayer (BAY) Advance Endometriosis Programme Into Phase I Clinical Development And Extend Alliance
GeoVax Labs (GOVX.OB) Joins With The Scripps Research Institute And Institute of Human Virology At University Of Maryland School Of Medicine To Develop Lassa Fever Vaccine
Sernova Corp. (SVA.TO)-HemAcure Consortium Announce Significant Progress In Development Of ‘First In World’ Regenerative Medicine Therapy For Treatment Of Hemophilia A Patients
4D Molecular Therapeutics And Foundation Fighting Blindness Partner To Develop Gene Therapies For Retinal Diseases
FDAnews Joins WIRB-Copernicus Group
Admera Health Partners With Helix To Launch Genetic Tests To Assess The Risk Of Inherited High Cholesterol, Sudden Cardiac Death, And Inherited Diabetes
DARA BioSciences Announces Memorandum Of Understanding With For The Conduct Of The Ovaprene Postcoital Test Clinical Trial
iBio, Inc. (IBIO) Enters Into Common Stock Purchase Agreement For Up To $16.0 Million With Lincoln Park Capital
Trimedx Selects Pilgrim Quality Solutions To Expedite Key Quality Management Processes
Innovus Pharma Announces Combined Launch Of Apeaz Cream For Arthritis Pain Relief, And Arthrivarx, A Supplement Designed To Maximize And Support Joint Health
AMAG (AMAG) Launches Intrarosa (Prasterone) In The U.S. – A Novel Product To Treat Moderate To Severe Dyspareunia Due To Menopause
Merck & Co. (MRK) Announces U.S. Launch Of RENFLEXIS (Infliximab-Abda), A Biosimilar Of Remicade, For All Eligible Indications
Samsung Bioepis Announces RENFLEXIS (Infliximab-Abda) Now Available In The United States
Allegro Ophthalmics LLC Secures $10.7 Million In Private Financing
ESSA Pharma Provides Further Update On Proposed Equity Offering
Genetic Technologies Limited (GTG.AX) Receives Nasdaq Deficiency Notice
Axim Biotech: Cannabinoid Potential Worth The Complexity --
Sarepta (SRPT) Announces Proposed $250 Million Public Offering Of Common Stock
Novo Nordisk A/S (NVO) - Share Repurchase Programme
Cyclacel Pharma (CYCC) Announces Closing Of $15.2 Million Underwritten Public Offering And Full Exercise Of Over-Allotment Option
Achaogen (AKAO) Announces New Employment Inducement Grants
Ablynx (ABLYF) Announces Warrant Exercise
Marrone Bio Innovations, Inc Expands Its Products To Africa
Easton Pharmaceuticals (OP: EAPH) Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics And Treatment Segment
MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives
Amphastar (AMPH) Announces Jury Verdict In Patent Litigation Against Momenta (MNTA) And Sandoz
Cytovance Completes Its First FDA General Inspection Of Oklahoma City, Ok Facilities
Cannabics Pharma Establishes A Human-Cannabis-Cancer Genetics Lab To Expand Its Personalized Diagnostics
Exploragen Launches Its First DNA-Powered App On Helix Marketplace
Aralez To Report Second Quarter 2017 Financial Results On August 9, 2017
Alimera Sciences (ALIM) To Report Second Quarter 2017 Financial Results On August 2nd, 2017
Biocryst (BCRX) To Announce Second Quarter 2017 Financial Results On August 7
CryoPort To Report Second Quarter 2017 Financial Results On August 8th, 2017
Compugen Ltd. (CGEN) Second Quarter 2017 Conference Call Scheduled For Wednesday, August 2, 2017 At 10:00 AM ET
Coherus To Report Second Quarter 2017 Financial Results On August 7th
Galmed Pharmaceuticals Second Quarter 2017 Conference Call And Webcast Scheduled For Monday, July 31, 2017
Invitae To Announce Second Quarter 2017 Financial Results And Host Conference Call On August 7, 2017
Invacare (IVC) To Host Conference Call And Webcast To Discuss Second Quarter 2017 Financial Results
Kindred Bio (KIN) To Announce Second Quarter 2017 Financial Results
Lexicon Pharma (LXRX) To Host Second Quarter 2017 Financial Results Conference Call And Webcast On August 1, 2017
Sunesis (SNSS) To Host Conference Call On July 27th To Discuss Second Quarter 2017 Financial Results And Recent Highlights
United Therapeutics (UTHR) To Report Second Quarter 2017 Financial Results Before The Market Opens On Thursday, July 27, 2017
ZIOPHARM Oncology (ZIOP) To Host Second-Quarter 2017 Financial Results And Corporate Update Conference Call On July 31, 2017 At 4:30 P.M. ET
Oxford Immunotec (OXFD) Appoints Richard Wenstrup, MD, As Chief Medical Officer
zuChem Announces Appointment Of Dan Cummings As Chief Operating Officer & General Counsel
Microbix Biosystems Inc. (MBXBF) Announces Leadership Transition
Cancer Immunotherapy Company Vaxil BioTherapeutics Appoints Dr. Terry Plasse As Chief Medical Officer
Merrimack (MACK) Appoints Thomas Needham As Chief Business Officer
Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President Of Corporate Development And Strategy
Dimension Therapeutics (DMTX) Announces Management Change
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., To Board Of Directors
Deinove Strengthens Its Business Development Activity With The Arrival Of Sébastien Enault
Minerva Neurosciences (NERV) Announces Departure Of Directors
Lucideon Welcomes HyMedPoly Students
Microbiotix, Inc. Announces Leadership Transition
Reviva Pharma Announces Addition Of A New Member To Its Board Of Directors
Teleflex Inc. (TFX)'s Arrow Seldinger Arterial Catheterization Device Nabs FDA Market Clearance
Luminex (LMNX) Grabs FDA Clearance for ARIES C. difficile Assay
Abbott (ABT) Divests Alere (ALR)'s Epocal Blood Dx Biz to the Siemens Healthineers (SI) for Undisclosed Sum
Leading Advisory Firms ISS And Glass Lewis Support Plan Of Arrangement Between Novadaq And Stryker (SYK)
OraSure Tech (OSUR) Release: OraQuick HIV Self-Test Selected For Next Phase Of STAR Project For HIV Self-Testing In Africa
OncoCyte Analytical Validation Study Of Its Lung Cancer Diagnostic Test Confirms Previously Published Results
Gurnet Point L.P. Completes Acquisition Of Innocoll (INNL)
SQI Diagnostics Partners With McMaster University To Co-Develop "Instant Immunoassay" Testing Technology
EXACT Sciences (EXAS) Grants Inducement Restricted Stock Unit Awards To Recently Hired Employees
Fluicell Receives A New Patent Acceptance For The BioPen System
RevMedx Unveils New Pricing On XSTAT Hemostatic Devices To Enable Broader Access To Life-Saving Treatment For Gunshot Wounds
Paragon 28 Expands Innovative Product Portfolio With The Launch Of The PROMO Triplanar Hallux Valgus Correction System
Copan Diagnostics, Inc.. Showcasing PhenoMATRIX Smart Algorithms At AACC In San Diego
Omnicell (OMCL) Launches XT Series Automated Dispensing Cabinets For Supply Management
Millipede Announces First Cases With 50mm Transcatheter Annuloplasty Ring Expanding Treatable Patient Population
Samsung NeuroLogica Introduces BodyTom Elite CT Scanner
SpeeDx Eyes Clear Path Toward Marketing Antibiotic Resistance And Detection Tests In US Market
REMSleep Holdings Inc. ANNOUNCES THE DeltaWave And Its Patent Application -- A New Revolutionary CPAP Nasal Interface Device Designed To Improve Treatment For Sleep Apnea Patients
FemTech Startup EZbra Presented At youngStartup's Venture Summit In New York
Paradigm Diagnostics Announces Major Price Reduction in Flagship Paradigm Cancer Diagnostic (PCDx)
Small Details, Big Difference: New White Paper From Mettler-Toledo (MTD) Details Safe Weighing In 3 Steps
GeneSeeq Raises "Hundred of Millions Of RMB" In C Round To Develop NGS
Coloplast (COLOB.CO) Release: Share Buy-Back Week 29/2017
The Key To Bedfont Scientific's International Success
Sientra (SIEN) To Release Second Quarter 2017 Financial Results And Host Conference Call On Wednesday, August 9, 2017
Notal Vision Names Jim Long As Chief Financial Officer
Definiens AG Forearms Organization For Strategic Expansion
SynDaver Labs Expands Executive Leadership Team, Continues Growth, Prepares For IPO
Elekta Introduces Advanced Cancer Treatment To Kingdom Of Bhutan
Semler Scientific To Report Second Quarter 2017 Financial Results And Host Conference Call On August 2, 2017
TransMed7 Announces Jack Cumming As Director